Skip to main navigation Skip to search Skip to main content

Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma

  • Kartik Kesavabhotla
  • , Cody D. Schlaff
  • , Benjamin Shin
  • , Lynn Mubita
  • , Rachel Kaplan
  • , Apostolos J. Tsiouris
  • , Susan C. Pannullo
  • , Paul Christos
  • , Ehud Lavi
  • , Ronald Scheff
  • , John A. Boockvar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science